Frontlight ResearchEarly access
Taking peopleNo phase
Super Chinese Nephrotic Syndrome Registration System (SUCCESS)
Key facts
- Who runs it
- Sun Yat-sen University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 5,000 people, planned
- Started
- Apr 2016
- Expected to end
- Dec 2029
- Type of study
- Observational
- Record updated
- 15 September 2026
Who can take part
- Age
- 14 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Nephrotic syndrome patients regardless of the primary causes
Who cannot take part
- No
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The investigators are registering all nephrotic syndrome (NS) patients regardless of the primary causes and developing a NS database in China. Patients will be followed-up and both baseline and follow-up information will be recorded in the registration system. The treatment response, longitudinal changes of renal function, renal survival, patient survival, infection events and acute kidney injury etc, will be analyzed using the NS database.
The group in the trial
- Nephrotic syndrome patients
Patients diagnosis as nephrotic syndrome (NS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 15 September 2026